Molecular recognition and modification of the 30S ribosome by the aminoglycoside-resistance methyltransferase NpmA

Jack A Dunkle1, Kellie Vinal, Pooja M Desai

  • 1Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322.

Insights

We uncovered the structural basis of how a novel enzyme, NpmA, modifies bacterial ribosomes to resist aminoglycoside antibiotics. This methylation process is crucial for bacterial survival against these drugs.

Area of Science:

  • Structural Biology
  • Microbiology
  • Molecular Biology

Background:

  • Aminoglycosides are critical antibiotics targeting bacterial ribosomes.
  • Antibiotic resistance, particularly to aminoglycosides, is a major global health threat.
  • Novel resistance mechanisms, like those involving rRNA methyltransferases, require detailed structural understanding.

Purpose of the Study:

  • To elucidate the structural basis of 30S ribosomal subunit recognition by the NpmA methyltransferase.
  • To define the molecular mechanisms by which NpmA confers aminoglycoside resistance through m(1)A1408 modification.
  • To provide a structural framework for understanding aminoglycoside-resistance rRNA methyltransferases.

Main Methods:

  • X-ray crystallography to determine the structure of NpmA bound to the 30S subunit.
  • Biochemical assays to assess NpmA activity and substrate requirements.
  • Functional assays to confirm NpmA's role in conferring antibiotic resistance.

Main Results:

  • The structure reveals how NpmA recognizes the mature 30S ribosomal subunit by interacting with four distinct 16S rRNA helices.
  • A "precatalytic state" was captured, showing key residue rearrangements orienting A1408 for methylation.
  • NpmA catalyzes the m(1)A1408 modification, a key step in conferring resistance to aminoglycosides.

Conclusions:

  • The study provides unprecedented structural insight into NpmA-mediated aminoglycoside resistance.
  • The findings highlight the importance of 30S subunit assembly for NpmA substrate recognition.
  • This work offers a molecular paradigm for other late-acting ribosome modification enzymes.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
10.2K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
61.3K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
9.4K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
877